# Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma

> **NCT02449135** · — · NO_LONGER_AVAILABLE · sponsor: **Fuda Cancer Hospital, Guangzhou**

## Conditions studied

- Pancreatic Cancer

## Interventions

- **PROCEDURE:** interventional therapy

## Key facts

- **NCT ID:** NCT02449135
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2021-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02449135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02449135, "Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02449135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*